Acorah Software Products - Accounts Production 19.3.550 false true false true No description of principal activity 2 November 2024 30 November 2025 30 November 2025 16056513 D Sboukis iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16056513 2024-11-01 16056513 2025-11-30 16056513 2024-11-02 2025-11-30 16056513 frs-core:CurrentFinancialInstruments 2025-11-30 16056513 frs-core:Non-currentFinancialInstruments 2025-11-30 16056513 frs-bus:PrivateLimitedCompanyLtd 2024-11-02 2025-11-30 16056513 frs-bus:FilletedAccounts 2024-11-02 2025-11-30 16056513 frs-bus:Micro-entities 2024-11-02 2025-11-30 16056513 frs-bus:AuditExempt-NoAccountantsReport 2024-11-02 2025-11-30 16056513 frs-bus:Director1 2024-11-02 2025-11-30
Registered number: 16056513
Dermopolis Ltd
Unaudited Financial Statements
For the Period 2 November 2024 to 30 November 2025
Balance Sheet
Registered number: 16056513
30 November 2025
£
Fixed assets 1,911
Current assets 288,107
Creditors: Amounts Falling Due Within One Year (73,661 )
NET CURRENT ASSETS 214,446
TOTAL ASSETS LESS CURRENT LIABILITIES 216,357
Creditors: Amounts Falling Due After More Than One Year (286 )
NET ASSETS 216,071
CAPITAL AND RESERVES 216,071

Notes

1. General Information
Dermopolis Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16056513 . The registered office is 231 Twickenham Road, Isleworth, TW7 6DH.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
D Sboukis
Director
14/07/2026